Browse Related Topics For:

Off-Label Promotion

97
Pharmaceutical Industry
95
FDA
60
First Amendment
53
Prescription Drugs
52
Off-Label Use
45
FDCA
38
Amarin
33
Medical Devices
28
Free Speech
24
Commercial Speech
24
False Claims Act (FCA)
24
Misbranding
21
Marketing
17
DOJ
16
Preliminary Injunctions
15
Caronia
15
Healthcare
11
FDA Approval
11
Popular
11
Qui Tam
10
FDA Warning Letters
9
Physicians
9
Preemption
8
Enforcement Actions
8
Health Care Providers
8
Whistleblowers
7
Life Sciences
7
Medicare
7
SCOTUS
6
Anti-Kickback Statute
6
Compliance
6
Failure To Warn
6
Fraud
6
Kickbacks
6
Medicaid
6
Product Labels
5
Advertising
5
Criminal Prosecution
5
Draft Guidance
5
False Advertising
5
GlaxoSmithKline
5
Hospitals
5
Settlement
4
Allergan Inc
4
Class Action
4
Clinical Trials
4
Dismissals
4
FCPA
4
Fifth Amendment
4
Financial Conduct Authority (FCA)
4
HHS
4
Johnson & Johnson
4
Labeling
4
Pleading Standards
4
RICO
3
Administrative Procedure Act
3
Affordable Care Act
3
Amicus Briefs
3
Birth Defects
3
CMS
3
Corporate Counsel
3
Corporate Integrity Agreement
3
Data Security
3
Enforcement
3
FFDCA
3
FTC
3
Generic Drugs
3
Injunctive Relief
3
InterMune
3
Misleading Statements
3
Misrepresentation
3
OIG
3
Public Disclosure
3
Relators
2
3D Printing
2
510(k) RTA
2
Abbott Laboratories
2
Amended Regulation
2
ANDA
2
Anti-Competitive
2
Biosimilars
2
Celebrity Endorsements
2
Cephalon
2
Choice-of-Law
2
Civil Monetary Penalty
2
Class Certification
2
Comment Period
2
Commercial Marketing
2
Cybersecurity
2
Daubert Standards
2
Design Defects
2
Dietary Supplements
2
Discovery
2
Due Process
2
FCC
2
Federal Question Jurisdiction
2
FTCA
2
Health Information Technologies
2
Indictments
2
Insurance Industry
2
Interstate Commerce
2
Kim Kardashian
2
Manufacturers
2
Medicare Part D
2
Medtronic
2
Motion to Amend
2
Negligence
2
Negligent Misrepresentation
2
Novartis
2
OPDP
2
Orphan Drugs
2
Pending Legislation
2
PHRMA
2
Precision Medicine Initiative (PMI)
2
Predominance Requirement
2
Product Defects
2
Proposed Amendments
2
Proposed Regulation
2
Public Health
2
Ripeness
2
Safe Harbors
2
SEC
2
Strict Liability
2
Unfair or Deceptive Trade Practices
2
Warning Labels
2
Wire Fraud
2
Yates Memorandum
1
21st Century Cures Initiative
1
Actual Injuries
1
Alzheimer's
1
Amazon
1
Amgen Inc. v Connecticut Retirement Plans
1
Anti-Bribery
1
Anti-Corruption
1
Anti-Money Laundering
1
Appeals
1
Appellate Review
1
Arbitration
1
Arbitration Agreements
1
Article III
1
Attorney Generals
1
Audit Policies
1
Below-Cost Pricing
1
Bifurcation
1
Board of Directors
1
Botox
1
BPCIA
1
Brand
1
Breach of Warranty
1
Bribery
1
Bristol-Myers Squibb
1
Cancer
1
Causation
1
CEOs
1
CFPB
1
Chilling Effect
1
Clinical Laboratories
1
Compelled Speech
1
Compensation Standards
1
Compensatory Damages
1
Constructive Posession
1
Contingency Fees
1
Contract Drafting
1
Corporate Officers
1
Cost-Sharing
1
Criminal Conspiracy
1
Cross-Border Transactions
1
Cyber Attacks
1
Cyber Insurance
1
D&O Insurance
1
Damages
1
Data Brokers
1
Data Privacy
1
Data Protection
1
De Novo Standard of Review
1
Declaratory Judgments
1
Declaratory Relief
1
Declination
1
Disclaimers
1
Dispute Resolution
1
Diversity Jurisdiction
1
DMEPOS
1
Do Not Disturb
1
Dodd-Frank
1
Drug Approvals
1
Durable Medical Equipment
1
Duty to Defend
1
Electronic Records
1
Eleventh Amendment
1
Evidence
1
Ex Post Facto Clause
1
Expert Witness
1
Fair Notice
1
False Billing
1
False Statements
1
Federal Arbitration Act
1
Federal Register
1
Federal v State Law Application
1
FERA
1
First-to-File
1
Foreign Financial Accounts
1
Forum Non Conveniens
1
Fraud Abuse and Waste
1
Fraudulent Concealment
1
Fraudulent Joinder
1
FTC v Actavis
1
Good Clinical Practices
1
Government Investigations
1
Grable Factors
1
GRAS
1
Guidance Update
1
Hackers
1
Health Insurance
1
Healthcare Facilities
1
Healthcare Fraud
1
Healthcare Reform
1
HEAT
1
Heightened Scrutiny
1
Hiring & Firing
1
Home Health Care
1
Honest Services Fraud
1
Hospice
1
HRSA
1
Humana
1
ICD-10
1
Illegal Gratuities
1
Individual Accountability
1
Inducements
1
Injunctions
1
Innovator Liability
1
Instagram
1
Intent of the Parties
1
International Arbitration
1
Investigational New Drug Application (IND)
1
Ireland
1
Israel
1
Janssen Pharmaceuticals
1
Jury Instructions
1
Jury Trial
1
Jury Verdicts
1
Kaiser Permanente
1
KBR v ex rel Carter
1
Lanham Act
1
Law Practice Management
1
Leave to Amend
1
Legislative Committees
1
Letters Rogatory
1
Libor
1
Litigation Hold
1
Loss of Consortium
1
Mass Tort Litigation
1
Medicaid Expansion
1
Medicaid Reimbursements
1
Medicare Advantage
1
Merck
1
Misleading Impressions
1
MLAT
1
Mobile Apps
1
Morgan Stanley
1
Motion to Compel
1
Motion to Dismiss
1
Motion to Remand
1
Multidistrict Litigation
1
Negligence Per Se
1
Negligent Infliction of Emotional Distress
1
Non-Compete Agreements
1
Northern Ireland
1
Nurses
1
Nursing Homes
1
Obama Administration
1
OMB
1
OMIG
1
Par Pharmaceutical
1
Patents
1
Patient Safety
1
Payday Loans
1
Penalties
1
Personal Jurisdiction
1
Personal Liability
1
Personalized Medicine
1
Personally Identifiable Information
1
PF Chang's
1
Pfizer
1
Pharmacies
1
Physician Compensation Arrangements
1
Pleadings
1
PLIVA v Mensing
1
Policies and Procedures
1
Prescription Drug Coverage
1
Privacy Policy
1
Professional Liability
1
Public Health Insurance Marketplace
1
Punitive Damages
1
Putative Class Actions
1
Recordkeeping Requirements
1
Recruitment Policies
1
Reed v Town of Gilbert
1
Regulatory Agenda
1
Regulatory Standards
1
Remand
1
Removal
1
Required Documentation
1
Retailers
1
Risk Management
1
Risk-Based Approaches
1
Rule 23
1
Sanctions
1
Sarbanes-Oxley
1
Schering-Plough
1
Sealed Records
1
Section 340B
1
Section 5
1
Securities Fraud
1
Self-Reporting
1
SNDAs
1
Social Media
1
Sovereign Immunity
1
Standing
1
State Law Tort Claims
1
Statute of Limitations
1
Stem cells
1
Strategic Enforcement Plan
1
Takeda Pharmaceuticals
1
TCPA
1
Telemedicine
1
Third-Party
1
Tortious Interference
1
Trademarks
1
Travelers
1
TRICARE
1
Tuomey
1
U.S. Embassies
1
UK
1
USDA
1
Value-Based Purchasing
1
Visa Applications
1
Visas
1
Wage and Hour
1
Warning Letters
1
White Collar Crimes
1
Wrongful Death
1
Zofran